Related Experiment Videos
Characterization of a novel translational inhibitor from Leishmania mexicana promastigotes
1Instituto de Investigaciones Bioquímicas Fundación Campomar, Facultad de Ciencias Exactas y Naturales, University of Buenos Aires and CONICET, Argentina.
Abstract:
An inhibitory activity blocking protein synthesis elongation in several eukaryotic systems has been detected in Leishmania mexicana extracts. This factor, which competes with aminoacylation of tRNA and also affects the subsequent polymerization step, is a strong inhibitor of polypeptide synthesis induced by poly U in wheat-germ extracts or by endogenous mRNAs in rat liver cell-free systems. The purified translational inhibitor has shown to be essentially free of proteins. Several chemical and biochemical properties of the inhibition factor have supported the conclusion that it behaves as a 200 bases RNA with a high content of secondary structure.
Insights
Leishmania mexicana extracts contain a novel RNA inhibitor that blocks protein synthesis elongation by interfering with tRNA aminoacylation and polypeptide chain formation in eukaryotic systems.
Area of Science:
- Molecular Biology
- Parasitology
- Biochemistry
Background:
- Protein synthesis is a fundamental process in all living organisms.
- Leishmania mexicana is a parasite known to cause leishmaniasis.
- Understanding cellular mechanisms in parasites can reveal novel therapeutic targets.
Purpose of the Study:
- To identify and characterize factors from Leishmania mexicana that inhibit protein synthesis.
- To elucidate the mechanism of action of this inhibitory factor.
- To determine the molecular nature of the inhibitor.
Main Methods:
- Extraction and partial purification of inhibitory activity from Leishmania mexicana.
- Assays for protein synthesis inhibition using eukaryotic cell-free systems (wheat germ, rat liver).
- Biochemical characterization including protein content analysis and RNA analysis.
Main Results:
- A potent inhibitor of protein synthesis elongation was detected in Leishmania mexicana extracts.
- The inhibitor competes with tRNA aminoacylation and affects polypeptide polymerization.
- The purified inhibitor is not proteinaceous and exhibits properties of a ~200 base RNA with extensive secondary structure.
Conclusions:
- Leishmania mexicana produces a non-proteinaceous RNA inhibitor of eukaryotic protein synthesis.
- This RNA molecule interferes with key steps of translation, including tRNA charging and peptide bond formation.
- The inhibitor represents a potential target for antiparasitic drug development.